The FDA has approved Medicis’ hyaluronic acid with lidocaine dermal fillers, Restylane-L and Perlane-L. This approval was based on clinical data that demonstrated Restylane-L and Perlane-L to ...
Restylane Eyelight is the first and only product in the U.S. to use NASHA ® Technology to improve the appearance of undereye hollows for up to 18 months 1 DALLAS, June 5, 2023 /PRNewswire/ -- Galderma ...
SCOTTSDALE, Ariz., April 27, 2011 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the U.S. Food and Drug Administration's (FDA) General and Plastic Surgery Devices Advisory Panel (the ...
- Galderma reinforces long-term commitment to meet physician and patient needs in aesthetic and corrective dermatology worldwide Restylane, Perlane and Emervel are manufactured by Galderma and sold by ...
The FDA has approved Restylane® Kysse (Galderma) for lip augmentation and the correction of upper perioral rhytids in adults aged >21 years. The Food and Drug Administration (FDA) has approved ...
(MENAFN- PR Newswire) FORT WORTH, Texas, Sept. 30, 2021 /PRNewswire/ -- Galderma, the world's largest independent dermatology company, today marks the 25th anniversary of RESTYLANE®. Since launching ...
Men and nonsurgical facial procedures (i.e., in-office injectables, such as fillers like Restylane) are having a moment together—the numbers simply don't lie. Cosmetic surgery, as well as nonsurgical ...
(MENAFN- PR Newswire) FORT WORTH, Texas, Feb. 2, 2021 /PRNewswire/ -- Galderma announces that the U.S. Food and Drug Administration (FDA) has approved Restylane® Defyne for the augmentation and ...
Please provide your email address to receive an email when new articles are posted on . The FDA has granted market approval to Restylane Lyft with lidocaine for cheek augmentation and correction of ...
FORT WORTH, Texas, June 29, 2021 /PRNewswire/ -- Galderma announced today the U.S. Food and Drug Administration (FDA) has approved Restylane ® Contour for cheek augmentation and correction of midface ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results